Search papers, labs, and topics across Lattice.
1
0
0
9
Selective SIK2/SIK3 inhibition shows promise in reprogramming myeloid cells, potentially offering a novel therapeutic approach for autoimmune diseases by shifting the immune response from pro-inflammatory to regulatory.